Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

NCT00266643 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful

Interventions

DRUG: duloxetine hydrochloride

Sponsor

Eli Lilly and Company